TO ORDER OF CENTRIENT

Regarding your inquiry about "TO ORDER OF CENTRIENT" company in Taiwan:

It appears there might be a misunderstanding. "TO ORDER OF CENTRIENT" is not a company name itself. It is a common phrase used in banking, shipping, or legal documents, indicating that a payment or delivery is to be made as directed by "Centrient".

If you are referring to Centrient Pharmaceuticals, here is an introduction:

Company Introduction:

Centrient Pharmaceuticals is a global leader in the sustainable production of antibiotics, next-generation statins, and anti-fungals. Headquartered in the Netherlands, the company is dedicated to developing, producing, and commercializing high-quality, sustainably produced Active Pharmaceutical Ingredients (APIs) and intermediates. Their mission is to provide life-saving medicines while minimizing environmental impact through innovative enzymatic technologies.

Factory or Trading Company:

Centrient Pharmaceuticals is primarily a manufacturing company (factory). They operate large-scale production facilities where they synthesize pharmaceutical ingredients. While they also engage in global sales and distribution, their core identity and primary function is that of a producer of APIs.

Presence in Taiwan:

Centrient Pharmaceuticals operates globally. While they may have business relationships, distributors, or sales activities in Taiwan, they do not have primary manufacturing plants directly owned and operated by Centrient Pharmaceuticals located in Taiwan. Their main manufacturing sites are in countries like Spain, the Netherlands, and India.

CENTRIENT PHARMACEUTICALS (TAIWAN BRANCH) PRODUCTS AND SERVICES

1. ACTIVE PHARMACEUTICAL INGREDIENTS (APIs)

The company specializes in the large-scale manufacturing and supply of high-quality APIs, primarily focusing on beta-lactam antibiotics.

2. PENICILLIN-BASED PRODUCTS

Production includes various penicillin derivatives used as raw materials for finished pharmaceutical formulations.

3. CEPHALOSPORIN-BASED PRODUCTS

The company manufactures a wide range of cephalosporin APIs, which are widely utilized in global healthcare systems to treat bacterial infections.

4. SEMI-SYNTHETIC ANTIBIOTICS

The company utilizes advanced enzymatic technology to produce semi-synthetic antibiotics, emphasizing sustainable and environmentally friendly manufacturing processes.

5. PHARMACEUTICAL INTERMEDIATES

The company supplies key chemical intermediates required for the synthesis of complex antibiotic compounds.

6. CUSTOM MANUFACTURING SERVICES

Centrient provides contract manufacturing and technical support services for pharmaceutical partners looking to outsource the production of complex antibiotic components.